Press Release ClearNote Health Announces New Proprietary Approach for Predicting Immunotherapy Treatment Response in Non-Small Cell Lung Cancer Using Only Blood ClearNote Health January 16, 2024
Press Release ClearNote Health Announces Collaboration with Bayer to Investigate Drug Treatment Response by Liquid Biopsy in Prostate Cancer ClearNote Health December 14, 2023
Press Release ClearNote Health Joins the Pancreatic Cancer Early Detection (PRECEDE) Consortium in New Partnership to Reduce Cancer Mortality ClearNote Health November 2, 2023
Press Release Avantect Pancreatic Cancer Test Receives CPT Code and Preliminary Payment Determination from the Centers for Medicare and Medicaid Services ClearNote Health September 28, 2023
Press Release Study Validating ClearNote Health’s Avantect Pancreatic Cancer Detection Test Published in the Journal Clinical Gastroenterology and Hepatology ClearNote Health May 8, 2023
Press Release CEO Perspective: We are ClearNote Health – Allow Us to Re-Introduce Ourselves ClearNote Health December 21, 2022
Press Release Bluestar Genomics Advances to Commercial Phase, Rebrands as ClearNote Health ClearNote Health December 21, 2022
Press Release Bluestar Genomics Initiates One of the Largest Clinical Trials for Early Detection of Pancreatic Cancer ClearNote Health December 6, 2022
Press Release Bluestar Genomics Presents Positive Results from Validation Study in Pancreatic Cancer Detection at American Pancreatic Association (APA) Annual Meeting ClearNote Health November 2, 2022
Press Release Bluestar Genomics Receives CAP Accreditation for its Clinical Laboratory ClearNote Health October 10, 2022
